Select Medical Holdings CORP Form 4 insider transactions
NYSE
Christopher Weigl, Chief Accounting Officer of Select Medical Holdings Corp, reports the acquisition of 15,000 shares of common stock and disposal of 40,000 shares on April 30, 2024.
NYSE
Michael F. Malatesta, CFO of Select Medical Holdings, was granted 75,000 shares of restricted stock on April 30, 2024, which will vest in full on April 30, 2027.
NYSE
Form 4: Select Medical Holdings Executive Vice President Receives 138,000 Shares of Restricted Stock
Martin F. Jackson, Executive Vice President of Select Medical Holdings, acquired 138,000 shares of restricted stock on April 30, 2024, according to a Form 4 filing with the SEC.
NYSE
Form 4: Select Medical Holdings Corp: Co-President Mullin Receives 100,000 Shares of Restricted Stock
Thomas P. Mullin, Co-President of Select Medical Holdings Corp, acquired 100,000 shares of restricted stock on April 30, 2024, which will vest on April 30, 2027.
NYSE
Executive Vice President John A. Saich of Select Medical Holdings Corp. was granted 100,000 shares of restricted stock on April 30, 2024, which will vest on April 30, 2027.
NYSE
Michael Tarvin, Executive Vice President of Select Medical Holdings, reports acquiring 92,000 shares of common stock through a grant of restricted stock.
NYSE
David Chernow, President and CEO of Select Medical Holdings, acquired 230,000 shares of restricted stock on April 30, 2024, which will vest in equal annual installments over three years.
NYSE
Robert A. Ortenzio, Executive Chairman of Select Medical Holdings, reports the acquisition of 230,000 shares of common stock through a restricted stock grant.
NYSE
Director Daniel Thomas acquired 10,000 shares of Select Medical Holdings restricted stock on April 30, 2024, which will vest on April 30, 2025.
NYSE
Director Parvinderjit S. Khanuja acquired shares of Select Medical Holdings Corp, including restricted stock grants in lieu of a quarterly retainer.
NYSE
Director William H. Frist reports acquisition of Select Medical Holdings stock through restricted stock grants.
NYSE
Rocco A. Ortenzio, Executive Chairman of Select Medical Holdings, was granted 100,000 shares of restricted stock on April 30, 2024, which will vest annually over three years.
NYSE
Marilyn B. Tavenner, a director at Select Medical Holdings, received a grant of 10,000 shares of restricted stock on April 30, 2024.
NYSE
James S. Ely III, a director of Select Medical Holdings Corp, acquired 10,000 shares of common stock on April 30, 2024, through a grant of restricted stock.
NYSE
Director Katherine R. Davisson reported receiving a grant of 10,000 shares of Select Medical Holdings Corp. common stock and disposing of 46,000 shares on April 30, 2024.
NYSE
Robert G. Breighner JR, Vice President of Compliance at Select Medical Holdings Corp, reports changes in beneficial ownership of company stock due to tax withholding and a grant of restricted stock.
NYSE
Form 4: Select Medical Holdings Corp Director Thomas Scully Receives 10,000 Shares of Restricted Stock
Director Thomas Scully received 10,000 shares of restricted stock in Select Medical Holdings Corp, vesting fully on April 30, 2025.
NYSE
Director Russell L. Carson acquired 10,000 shares of restricted stock in Select Medical Holdings Corp, vesting on April 30, 2025.
NYSE
Robert Ortenzio, Executive Chairman of Select Medical Holdings, sold 50,000 shares of common stock at an average price of $29.90, according to a recent SEC filing.
NYSE
Robert Ortenzio, Executive Chairman of Select Medical Holdings, sold 50,000 shares of common stock at an average price of $28.30 on March 8, 2024, according to a Form 4 filing with the SEC.